<IPO>LEADS BIOLABS-B (09887.HK) Records Margin Oversubscription 1,300x+
Biotechnology firm LEADS BIOLABS-B (09887.HK) will end the IPO period tomorrow (22nd) at noon....
Biotechnology firm LEADS BIOLABS-B (09887.HK) will end the IPO period tomorrow (22nd) at noon.
As of around 9 am today (21st), various brokerages have lent a total of over HKD147.4 billion in margin financing for its IPO, according to market data. With the public offering aiming to raise up to HKD112 million, the margin oversubscription reached nearly 1,313 times.
LEADS BIOLABS-B has introduced TENCENT (00700.HK) as one of its 10 cornerstone investors for its IPO. Those investors collectively subscribed to shares equivalent to around USD69 million.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-07-18 16:25.)
Disclaimer: The views in this article are from the original Creator and do not represent the views or position of Hawk Insight. The content of the article is for reference, communication and learning only, and does not constitute investment advice. If it involves copyright issues, please contact us for deletion.
